Status:
COMPLETED
Comparative Study of Dual Yellow Laser Versus Stabilized Kilnman Preparation in the Treatment of Melasma
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Melasma
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Recent data highlight the role of vascularity in melasma and a recent study showed the interest to target this vascular component by pulsed dye laser. The Dual Yellow laser is a copper bromide laser e...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Age ≥ 18 years, ≤75 years.
- Clinical diagnosis of melasma
- Fitzpatrick phototype 1 to 4.
- Effective contraception will be maintained for the duration of the study.
- Affiliation to the Social Security
- Informed consent signed by the patient
Exclusion
- Pregnant or breastfeeding women; effective contraception will be maintained for the duration of the study.
- Fitzpatrick phototype ≥ 5
- Intolerance or allergy to compounds of
- Exposure to UV or concomitant exposure to the sun without 50+ protective shield.
- Concomitant topical treatments may be effective on melasma (topical corticosteroids, topical retinoids)
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01850186
Start Date
February 1 2012
End Date
September 1 2013
Last Update
February 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice - Hôpital Archet
Nice, Alpes-Maritimes, France, 06